Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes

Cancer cells tend to develop resistance to chemotherapy and enhance aggressiveness. A counterintuitive approach is to tame aggressiveness by an agent that acts opposite to chemotherapeutic agents. Based on this strategy, induced tumor-suppressing cells (iTSCs) have been generated from tumor cells an...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kexin, Sun, Xun, Li, Hudie, Ma, Hailan, Zhou, Meng, Minami, Kazumasa, Tamari, Keisuke, Ogawa, Kazuhiko, Pandya, Pankita H., Saadatzadeh, M. Reza, Kacena, Melissa A., Pollok, Karen E., Li, Bai-Yan, Yokota, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311056/
https://www.ncbi.nlm.nih.gov/pubmed/37397541
http://dx.doi.org/10.1016/j.gendis.2022.08.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311056/
https://www.ncbi.nlm.nih.gov/pubmed/37397541
http://dx.doi.org/10.1016/j.gendis.2022.08.007

Ejemplares similares